Literature DB >> 19968561

An integrated view of humoral innate immunity: pentraxins as a paradigm.

Barbara Bottazzi1, Andrea Doni, Cecilia Garlanda, Alberto Mantovani.   

Abstract

The innate immune system consists of a cellular and a humoral arm. Pentraxins (e.g., the short pentraxin C reactive protein and the long pentraxin PTX3) are key components of the humoral arm of innate immunity which also includes complement components, collectins, and ficolins. In response to microorganisms and tissue damage, neutrophils, macrophages, and dendritic cells are major sources of fluid-phase pattern-recognition molecules (PRMs) belonging to different molecular classes. Humoral PRMs in turn interact with and regulate cellular effectors. Effector mechanisms of the humoral innate immune system include activation and regulation of the complement cascade; agglutination and neutralization; facilitation of recognition via cellular receptors (opsonization); and regulation of inflammation. Thus, the humoral arm of innate immunity is an integrated system consisting of different molecules and sharing functional outputs with antibodies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19968561     DOI: 10.1146/annurev-immunol-030409-101305

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  216 in total

1.  Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.

Authors:  Anna Maria Gori; Betti Giusti; Benedetta Piccardi; Patrizia Nencini; Vanessa Palumbo; Mascia Nesi; Antonia Nucera; Giovanni Pracucci; Paolina Tonelli; Eleonora Innocenti; Alice Sereni; Elena Sticchi; Danilo Toni; Paolo Bovi; Mario Guidotti; Maria Rosaria Tola; Domenico Consoli; Giuseppe Micieli; Rossana Tassi; Giovanni Orlandi; Maria Sessa; Francesco Perini; Maria Luisa Delodovici; Maria Luisa Zedde; Francesca Massaro; Rosanna Abbate; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-07       Impact factor: 6.200

Review 2.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

Review 3.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

4.  Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.

Authors:  Je-In Youn; Michelle Collazo; Irina N Shalova; Subhra K Biswas; Dmitry I Gabrilovich
Journal:  J Leukoc Biol       Date:  2011-09-27       Impact factor: 4.962

5.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ruth Dubin; Michael Shlipak; Yongmei Li; Joachim Ix; Ian H de Boer; Nancy Jenny; Carmen A Peralta
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

6.  Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels.

Authors:  Jackson da Silva Gullo; Melina Moré Bertotti; Cláudia Carvalho Pestana Silva; Marcelo Schwarzbold; Alexandre Paim Diaz; Flávia Mahatma Schneider Soares; Fernando Cini Freitas; Jean Nunes; José Tadeu Pinheiro; Edelton Flavio Morato; Rui Daniel Prediger; Marcelo Neves Linhares; Roger Walz
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

7.  Protection by natural IgG: a sweet partnership with soluble lectins does the trick!

Authors:  Irene Puga; Andrea Cerutti
Journal:  EMBO J       Date:  2013-10-25       Impact factor: 11.598

8.  Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex.

Authors:  Suzhen Zhang; Ying-Ting Zhu; Szu-Yu Chen; Hua He; Scheffer C G Tseng
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

9.  C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis.

Authors:  Lin Zhang; Shan-Hui Liu; Tyler T Wright; Zhi-Yuan Shen; Hai-Yun Li; Wei Zhu; Lawrence A Potempa; Shang-Rong Ji; Alexander J Szalai; Yi Wu
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 10.  Development and translation of novel therapeutics targeting tumor-associated macrophages.

Authors:  David Kosoff; Joshua M Lang
Journal:  Urol Oncol       Date:  2018-11-17       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.